Review: taking Levetiracetam and Risperidone together


Summary

Drug interactions are reported among people who take Levetiracetam and Risperidone together. This review analyzes the effectiveness and drug interactions between Levetiracetam and Risperidone. It is created by eHealthMe based on reports of 462 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Levetiracetam and Risperidone >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Levetiracetam

Levetiracetam has active ingredients of levetiracetam. It is often used in epilepsy. (latest outcomes from Levetiracetam 8,287 users)

Risperidone

Risperidone has active ingredients of risperidone. It is often used in schizophrenia. (latest outcomes from Risperidone 16,390 users)

On Aug, 23, 2016

462 people who take Levetiracetam, Risperidone are studied.


Number of reports submitted per year:

Levetiracetam and Risperidone drug interactions.

Drug effectiveness over time:

Levetiracetam:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 50.0% - (1 of 2 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Risperidone:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 50.0% - (1 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 33.0% - (1 of 3 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Levetiracetam:
  • female: 33.0% - (2 of 6 people)
  • male: 50.0% - (1 of 2 people)
Risperidone:
  • female: 20.0% - (1 of 5 people)
  • male: 50.0% - (1 of 2 people)

Drug effectiveness by age:

Levetiracetam:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 100.0% - (1 of 1 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 50.0% - (1 of 2 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 50.0% - (1 of 2 people)
Risperidone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 100.0% - (1 of 1 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 2 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 100.0% - (1 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • drug ineffective
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • schizophrenia
  • dizziness
  • hypertension
  • mood altered
  • arteriosclerosis
  • blood glucose increased
  • blood thyroid stimulating hormone increased
1 - 6 months:
  • epilepsy
  • somnolence
  • tremor
  • convulsion
  • nausea
  • abnormal behaviour
  • aggression
  • asthenia
  • cardio-respiratory arrest
  • depression
6 - 12 months:
  • convulsion
  • urinary tract infection
  • muscular weakness
  • pneumonia
  • anxiety disorder
  • bedwetting
  • generalised anxiety disorder
  • irritable bowel syndrome
  • multiple sclerosis relapse
  • panic disorder
1 - 2 years:
  • cerebrovascular accident
  • convulsion
  • deep vein thrombosis
  • delirium tremens
  • diabetes mellitus
  • drug dependence
  • dysarthria
  • dysphagia
  • hallucination, auditory
  • headache
2 - 5 years:
  • diabetic neuropathy
  • abdominal pain
  • cerebrovascular accident
  • chest pain
  • pancreatitis chronic
  • polyp colorectal
  • suicidal behaviour
  • anxiety disorder
  • bedwetting
  • diabetes mellitus
5 - 10 years:
  • convulsion
  • depression
  • dyskinesia
  • movement disorder
  • pain
  • tardive dyskinesia
  • tremor
  • urinary retention
  • weight decreased
not specified:
  • convulsion
  • depression
  • confusional state
  • agitation
  • anxiety
  • lethargy
  • somnolence
  • tremor
  • drug ineffective
  • suicide attempt

Most common drug interactions by gender *:

female:
  • convulsion
  • agitation
  • epilepsy
  • drug ineffective
  • depression
  • nausea
  • tremor
  • urinary tract infection
  • anxiety
  • headache
male:
  • convulsion
  • somnolence
  • aggression
  • depression
  • confusional state
  • suicide attempt
  • thrombocytopenia
  • weight increased
  • lethargy
  • suicidal ideation

Most common drug interactions by age *:

2-9:
  • aggression
  • convulsion
  • drug ineffective
  • agitation
  • dyskinesia
  • psychomotor hyperactivity
  • rash
  • respiratory distress
  • affect lability
  • altered state of consciousness
10-19:
  • aggression
  • electrocardiogram qt prolonged
  • lethargy
  • tic
  • weight increased
  • blood prolactin increased
  • depression
  • musculoskeletal stiffness
  • suicidal ideation
  • anxiety
20-29:
  • schizophrenia
  • agitation
  • suicide attempt
  • dyskinesia
  • hallucination, auditory
  • intentional self-injury
  • oculogyric crisis
  • overdose
  • parkinsonism
  • tension
30-39:
  • convulsion
  • thrombocytopenia
  • agitation
  • grand mal convulsion
  • dystonia
  • hyponatraemia
  • metabolic disorder
  • myoclonus
  • platelet count decreased
  • confusional state
40-49:
  • convulsion
  • tremor
  • urinary tract infection
  • diabetes mellitus
  • asthenia
  • depression
  • dyspnoea
  • extrapyramidal disorder
  • psychotic disorder
  • suicide attempt
50-59:
  • somnolence
  • depressed level of consciousness
  • coma
  • epilepsy
  • hyponatraemia
  • psychotic disorder
  • headache
  • pain in extremity
  • urinary tract infection
  • asthenia
60+:
  • confusional state
  • lethargy
  • convulsion
  • alanine aminotransferase increased
  • depression
  • hypertension
  • pyrexia
  • anxiety
  • disorientation
  • loss of consciousness

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Levetiracetam and Risperidone?

Can you answer these questions?

More questions for: Levetiracetam, Risperidone

You may be interested in these reviews

More reviews for: Levetiracetam, Risperidone

On eHealthMe, Levetiracetam (levetiracetam) is often used to treat epilepsy. Risperidone (risperidone) is often used to treat schizophrenia. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.